论文部分内容阅读
Objective Alzheimer disease(AD)is a fatal neurodegenerative disorder characterized by progressive cognitive impairment and memory loss.
Research on the neuroprotective effects of CI-1206 in an APP/PS1 mouse model
【摘 要】
：
Objective Alzheimer disease(AD)is a fatal neurodegenerative disorder characterized by progressive cognitive impairment and memory loss.
【作 者】
：
【机 构】
：
Department of Physiology,Shanxi Medical University,Taiyuan,030001,China
【出 处】
：
The 6th FAONS Congress and 11th Biennial Conference of CNS(第
【发表日期】
：
2015年3期
其他文献
Amyloid plaques and tau tangles are common pathological hallmarks for Alzheimers disease(AD); however,reducing Aβ production failed to relieve the symptoms of AD patients.
Introduction Microglial activation contributes to neuroinflammation and neuronal damages in neurodegenerative disorders including Alzheimers and Parkinsons diseases.
Alzheimers disease(AD)is an age-related neurodegenerative disorder,and characterized by chronic progressive deterioration of cognition,learning and memory.
Beta-amyloid(Aβ)cascade theory is the most recognized pathogenesis of Alzheimers disease(AD).
Precious studies have demonstrated that estrogen affects iron metabolism in peripheral tissues.
Alzheimers disease(AD)is a degenerative disorder of the central nervous system,which often impairs learning and memory,emotion and cognitive function.
ɑ-Synuclein-induced internalization of NMDA receptors in hippocampal neurons is associated with redu
Abnormal α-synuclein(α-syn)expression and aggregation have been implicated in the pathogenesis of Parkinsons disease(PD),dementia with Lewy bodies(DLB),and Alzheimers disease(AD).
Tetramethylpyrazine nitrone protects retinal ganglion cells against N-methyl-D-aspartate induced inj
会议
Aging is associated with an increased risk for Parkinsons disease(PD)and dementia with Lewy bodies(DLB),in which alpha-synuclein(α-syn)oligomerization plays key pathogenic roles.